Sign in to view content

Predicting Long-term Response to Ranibizumab After Three Injections in Patients With Age-Related Macular Degeneration

Paul Hahn, MD, PhD, FASRS

Video
Published 2020

Related

Efficacy and Durability of Brolucizumab in Patients Being Transitioned From Prior Anti-VEGF Therapy
Scott D Walter, MD, MSc, FASRS
Annual Meeting Talks
2021
Treatment Burden and Vision Analysis of Anti-VEGF Therapies for the Treatment of Neovascular AMD
Rahul Komati, MD
Annual Meeting Talks
2020
Subretinal Delivery of RGX-314 for Neovascular AMD: End of Study Phase I/IIa Results
Lejla Vajzovic, MD, FASRS
Annual Meeting Talks
2021

Category: AMD-Neovascular

See more